Valley National Advisers’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Valley National Advisers’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,000	Closed	-$26K	–	716
2016 Q4	$26K	Hold	5,000	–	–	0.01%	306
2016 Q3	$23K	Hold	5,000	–	–	0.01%	293
2016 Q2	$20K	Hold	5,000	–	–	0.01%	312
2016 Q1	$16K	Hold	5,000	–	–	0.01%	333
2015 Q4	$23K	Hold	5,000	–	–	0.01%	283
2015 Q3	$24K	Buy	+5,000	New	+$32.3K	0.01%	282

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Valley National Advisers's DSCI Position: Q1 2017 in Review

Valley National Advisers sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 5,000 shares — an estimated $26K sold.

Valley National Advisers first reported a position in DSCI in Q3 2015 and held it in 6 quarters. The position peaked at $26K in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Valley National Advisers reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Valley National Advisers sold 5,000 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $26K.
Valley National Advisers first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2015 and held it in 6 quarters.
Valley National Advisers's Derma Sciences, Inc. Common Stock (DE) position peaked at $26K in Q4 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Valley National Advisers's 13F filing for Q1 2017, filed 12 May 2017.